These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


618 related items for PubMed ID: 27456869

  • 1. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J, van der Pol S, Nijland P, Amor S, Perron H.
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.
    Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, Sotgiu S, Bonetti B, Dolei A.
    J Gen Virol; 2007 Jan; 88(Pt 1):264-274. PubMed ID: 17170460
    [Abstract] [Full Text] [Related]

  • 4. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.
    Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, Manetti R, Dolei A.
    PLoS One; 2012 Jan; 7(9):e44991. PubMed ID: 23028727
    [Abstract] [Full Text] [Related]

  • 5. Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.
    Laufer G, Mayer J, Mueller BF, Mueller-Lantzsch N, Ruprecht K.
    Retrovirology; 2009 Apr 15; 6():37. PubMed ID: 19368703
    [Abstract] [Full Text] [Related]

  • 6. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
    Ruprecht K, Gronen F, Sauter M, Best B, Rieckmann P, Mueller-Lantzsch N.
    J Neurovirol; 2008 Apr 15; 14(2):143-51. PubMed ID: 18444086
    [Abstract] [Full Text] [Related]

  • 7. The aliens inside human DNA: HERV-W/MSRV/syncytin-1 endogenous retroviruses and neurodegeneration.
    Dolei A, Uleri E, Ibba G, Caocci M, Piu C, Serra C.
    J Infect Dev Ctries; 2015 Jul 04; 9(6):577-87. PubMed ID: 26142666
    [Abstract] [Full Text] [Related]

  • 8. Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis.
    Antony JM, Zhu Y, Izad M, Warren KG, Vodjgani M, Mallet F, Power C.
    AIDS Res Hum Retroviruses; 2007 Oct 04; 23(10):1251-6. PubMed ID: 17961112
    [Abstract] [Full Text] [Related]

  • 9. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
    Curtin F, Perron H, Kromminga A, Porchet H, Lang AB.
    MAbs; 2015 Oct 04; 7(1):265-75. PubMed ID: 25427053
    [Abstract] [Full Text] [Related]

  • 10. The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis.
    Dolei A.
    Mult Scler; 2018 Jan 04; 24(1):42-47. PubMed ID: 29307292
    [Abstract] [Full Text] [Related]

  • 11. MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
    Madeira A, Burgelin I, Perron H, Curtin F, Lang AB, Faucard R.
    J Neuroimmunol; 2016 Feb 15; 291():29-38. PubMed ID: 26857492
    [Abstract] [Full Text] [Related]

  • 12. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
    Morandi E, Tanasescu R, Tarlinton RE, Constantin-Teodosiu D, Gran B.
    Front Immunol; 2018 Feb 15; 9():3092. PubMed ID: 30740110
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases.
    Antony JM, Izad M, Bar-Or A, Warren KG, Vodjgani M, Mallet F, Power C.
    AIDS Res Hum Retroviruses; 2006 Dec 15; 22(12):1253-9. PubMed ID: 17209768
    [Abstract] [Full Text] [Related]

  • 14. pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.
    Kremer D, Gruchot J, Weyers V, Oldemeier L, Göttle P, Healy L, Ho Jang J, Kang T Xu Y, Volsko C, Dutta R, Trapp BD, Perron H, Hartung HP, Küry P.
    Proc Natl Acad Sci U S A; 2019 Jul 23; 116(30):15216-15225. PubMed ID: 31213545
    [Abstract] [Full Text] [Related]

  • 15. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
    Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C.
    Biochim Biophys Acta; 2011 Feb 23; 1812(2):162-76. PubMed ID: 20696240
    [Abstract] [Full Text] [Related]

  • 16. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.
    Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Van-der-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung HP.
    Mult Scler; 2012 Dec 23; 18(12):1721-36. PubMed ID: 22457345
    [Abstract] [Full Text] [Related]

  • 17. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes.
    Antony JM, Ellestad KK, Hammond R, Imaizumi K, Mallet F, Warren KG, Power C.
    J Immunol; 2007 Jul 15; 179(2):1210-24. PubMed ID: 17617614
    [Abstract] [Full Text] [Related]

  • 18. Human Endogenous Retrovirus Type W Envelope from Multiple Sclerosis Demyelinating Lesions Shows Unique Solubility and Antigenic Characteristics.
    Charvet B, Pierquin J, Brunel J, Gorter R, Quétard C, Horvat B, Amor S, Portoukalian J, Perron H.
    Virol Sin; 2021 Oct 15; 36(5):1006-1026. PubMed ID: 33770381
    [Abstract] [Full Text] [Related]

  • 19. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.
    Mameli G, Poddighe L, Astone V, Delogu G, Arru G, Sotgiu S, Serra C, Dolei A.
    J Virol Methods; 2009 Oct 15; 161(1):98-106. PubMed ID: 19505508
    [Abstract] [Full Text] [Related]

  • 20. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
    Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, Maida I, Babudieri S, Serra C, Manetti R, Mura MS, Dolei A.
    PLoS One; 2013 Oct 15; 8(11):e78474. PubMed ID: 24236019
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.